Sitemap

US Pharma Firm Moderna Says Its COVID-19 Vaccine Is 94.5% Effective

More...

America’s Biggest Owner Of Farmland Is Now Bill Gates

Bill Gates, the fourth richest person in...

Chairperson-In-Office Ann Linde Presents Sweden’s 2021 Priorities To Permanent Council

Over the coming year, the Swedish Chairpersonship...

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in...

Environmental Protection – EU-Serbia Cooperation

The year behind us was certainly challenging...

News

Chairperson-In-Office Ann Linde Presents Sweden’s 2021 Priorities To Permanent Council

Over the coming year, the Swedish Chairpersonship will do its part to ensure that the OSCE can make a...

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in Tokyo has reignited speculation about the Olympic Games, which are due to open...

Environmental Protection – EU-Serbia Cooperation

The year behind us was certainly challenging in terms of health protection. Healthy environment was an essential aspect of...

EU Commission Concludes Exploratory Talks With Valneva To Secure A New Potential Vaccine

European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against...

Preconditions For Beginning Of Mass Vaccination Provided

Prime Minister Ana Brnabic pointed out today that there will be enough vaccines available for all citizens who want...

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.

US pharmaceutical firm Moderna announced on Monday that early analysis of its COVID-19 vaccine suggested it was as much as 94.5% effective.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stephane Bancel, Moderna’s CEO.

The news comes a week after Pfizer and their German partners BioNTech announced that their vaccine had reached 90% effectiveness. Russian researchers claimed similar success for its Sputnik V vaccine later that same day.

“Vaccines rely on observing natural infection in the community,” epidemiologist Eric Feigl-Ding told DW. “And then you can make conclusions. Infections are soaring across the world, and that actually allows you to see the effects much quicker.”

Coronavirus cases topped 11 million in the US over the weekend, with 1 million recorded in just the past week.

The pandemic has killed more than 1.3 million people worldwide, more than 245,000 of them in the U.S.

Moderna said it was confident it would receive emergency approval for its vaccine from US authorities in December.

Higher storage temperature

Both the Pfizer and Moderna vaccines are based on a new platform called messenger RNA, which is faster to produce than traditional vaccines.

Moderna’s vaccine was co-developed by the US National Institutes of Health and consists of two doses 28 days apart.

The company announced that its vaccine can remain stable at standard refrigerator temperatures of 2 degrees Celsius to 8 degrees Celsius (36 degrees Fahrenheit to 46 degrees Fahrenheit) for 30 days. Pfizer’s vaccine, on the other hand, needs to be stored in deep-freezer conditions which could complicate supply chain logistics.

EU: more vaccines coming

The European Commission said on Monday that Moderna’s announcement was encouraging and that the bloc was working to secure more supply deals with vaccine makers.

“More encouraging news from #COVID19 vaccine trials w/@moderna,” EU health commissioner Stella Kyriakides said on Twitter.

Source: deutsche welle

Related Articles

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in Tokyo has reignited speculation about the Olympic Games, which are due to open in the city in just...

EU Commission Concludes Exploratory Talks With Valneva To Secure A New Potential Vaccine

European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with...

Preconditions For Beginning Of Mass Vaccination Provided

Prime Minister Ana Brnabic pointed out today that there will be enough vaccines available for all citizens who want to be vaccinated against coronavirus. During...

Commission Adopts €70 Million Package For Early Access To EU COVID-19 Vaccines In The Western Balkans

European Commission adopted a package of €70 million under the Instrument for Pre-Accession (IPA II) to help fund the access of Western Balkans partners...

Serbia Has Started Vaccination Against Coronavirus

Exactly 293 days after the first case of COVID-19 was recorded in Serbia, vaccination against the coronavirus, which has so far claimed more than...

First Shipment Of Pfizer-BioNTech Vaccine Arrives In Serbia

The first shipment of Pfizer-BioNTech vaccine containing 4,800 doses has arrived in Serbia today and has been picked up at Nikola Tesla Airport in...

Coronavirus Mutation No Reason To Panic: Virologist

The new variant of COVID-19 found in the UK may spread quickly, but that doesn't mean it's more dangerous. The newly developed vaccines will...

EU Approves BioNTech-Pfizer COVID Vaccine

Approvals from regulators and the European Commission will let countries begin coronavirus vaccinations before the end of the year. EU nations are currently grappling...